HIV vaccines
The Human immunodeficiency virus (HIV) vaccine can either protect individuals from being infected with HIV or treat HIV-infected individuals. The virus can be transmitted through infected blood, sexual intercourse (semen or vaginal fluids). AIDS also called Acquired Immunodeficiency Syndrome is caused by HIV where it interferes with the body’s ability to fight infections. Common symptoms of AIDS include weight loss, fever, fatigue, and recurrent infections. An HIV vaccine can either induce an immune response against HIV or consist of preformed antibodies against HIV. Two active HIV vaccine regimens are studied in the RV 144 and Imbokodo trials, which showed the results that it helped to prevent HIV in some individuals. However, the protection was observed in only a few individuals and was not long-lasting results. For these reasons, no HIV vaccines have been licensed in the market yet but research is still going on.
Related associations and societies: National Institutes of Health (NIH) , Immune Deficiency Foundation (IDF),National Institute of Allergy and Infectious Diseases (NIAID), National Medical Association (NMA), Federation of Clinical Immunology Societies (FOCIS), Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI), Clinical Immunology Society, Hepatitis B Foundation (HBF), Pediatric Infectious Diseases Society(PIDS), Indian Vaccine Manufacturers Association (IVMA).
Related Conference of HIV vaccines
7th International Conference on Vaccines, Immunology and Clinical Trials
HIV vaccines Conference Speakers
Recommended Sessions
- Advancements of Vaccines
- Adverse effects of Vaccination
- Anti-bodies and Viral Diseases
- Antibiotics
- Bio Markers and Case Reports
- Clinical Trials
- Corona Virus
- Emerging Infectious Diseases
- Geriatric immunization
- HIV vaccines
- Immunization for pregnant & Lactating women
- Immunology
- Insulin and Insulin Therapy
- Pediatric Vaccines
- Plant-Based Vaccines
- Travel Immunization
- Vaccine Guidelines
- Vaccine Manufacturing Technologies
- Vaccine research and Development
- Vaccine safety and Efficacy
- Vaccines
- Vaccines and its types
- Vaccines Associated with Cancer
- Viral Mutations and Variants
- Virology & Microbiology
Related Journals
Are you interested in
- Antiviral Therapies - Virology 2024 (Austria)
- Basic Immunology - Virology 2024 (Austria)
- Challenges in Global Vaccination Programs - Vaccines R&D 2024 (Netherlands)
- Clinical Immunology - Virology 2024 (Austria)
- Clinical Trials: Safety, Efficacy, and Beyond - Vaccines R&D 2024 (Netherlands)
- COVID19 Vaccines - VACCINE CONGRESS 2024 (Spain)
- Cutting-Edge Techniques in Vaccine Manufacturing - Vaccines R&D 2024 (Netherlands)
- Emerging Infectious Diseases and Global Health - VACCINES WORLD 2024 (Canada)
- Emerging Viral Diseases - Virology 2024 (Austria)
- Epidemiology and Public Health - Virology 2024 (Austria)
- Ethical and Societal Aspects of Vaccination - VACCINES WORLD 2024 (Canada)
- Gene Editing for Vaccine Development - Vaccines R&D 2024 (Netherlands)
- Geriatric Vaccines - VACCINE CONGRESS 2024 (Spain)
- Global Vaccine Access - VACCINE CONGRESS 2024 (Spain)
- Immune System and Non-Infectious Diseases - Vaccines R&D 2024 (Netherlands)
- Immunization in Special Populations - VACCINES WORLD 2024 (Canada)
- Immunodiagnostics and Monitoring Immune Responses - VACCINES WORLD 2024 (Canada)
- Immunogenetics and Genomics - Virology 2024 (Austria)
- Immunogenetics and Personalized Vaccinology - VACCINES WORLD 2024 (Canada)
- Immunology and Infectious Diseases: Current Landscape - Vaccines R&D 2024 (Netherlands)
- Immunology of Aging and Vaccination - Vaccines R&D 2024 (Netherlands)
- Immunology of Vaccines - VACCINE CONGRESS 2024 (Spain)
- Immunometabolism - Virology 2024 (Austria)
- Immunopathology and Host-Pathogen Interactions - VACCINES WORLD 2024 (Canada)
- Immunotherapy - Virology 2024 (Austria)
- Immunotherapy: Novel Strategies and Technologies - Vaccines R&D 2024 (Netherlands)
- Infectious Diseases and Immunity - Virology 2024 (Austria)
- Inflammation and Immune Response - Virology 2024 (Austria)
- Innate and Adaptive Immune Responses - VACCINES WORLD 2024 (Canada)
- Innovative Approaches to Vaccine Design - Vaccines R&D 2024 (Netherlands)
- Innovative Immunotherapies - VACCINES WORLD 2024 (Canada)
- Next Generation Vaccines - VACCINE CONGRESS 2024 (Spain)
- Next-Generation Vaccines: Advancements and Challenges - Vaccines R&D 2024 (Netherlands)
- Novel Vaccine Platforms - VACCINE CONGRESS 2024 (Spain)
- One Health Approach - VACCINE CONGRESS 2024 (Spain)
- Paediatric Vaccines - VACCINE CONGRESS 2024 (Spain)
- Precision Medicine and Personalized Vaccines - Vaccines R&D 2024 (Netherlands)
- Public Health and Vaccination Programs - VACCINES WORLD 2024 (Canada)
- Public-Private Partnerships for Vaccine Research - Vaccines R&D 2024 (Netherlands)
- Regulatory Guidelines for Vaccine Approval - Vaccines R&D 2024 (Netherlands)
- The Future of Vaccinology: Trends and Prospects - Vaccines R&D 2024 (Netherlands)
- Vaccination Strategies for Vector-Borne Diseases - VACCINES WORLD 2024 (Canada)
- Vaccine Adjuvants - VACCINE CONGRESS 2024 (Spain)
- Vaccine Clinical Trials - VACCINE CONGRESS 2024 (Spain)
- Vaccine Delivery Systems - VACCINE CONGRESS 2024 (Spain)
- Vaccine Development - Virology 2024 (Austria)
- Vaccine Development and Design - VACCINES WORLD 2024 (Canada)
- Vaccine Development for Emerging Diseases - VACCINE CONGRESS 2024 (Spain)
- Vaccine Economics and Market Access - VACCINES WORLD 2024 (Canada)
- Vaccine Education and Advocacy - VACCINES WORLD 2024 (Canada)
- Vaccine Equity - VACCINE CONGRESS 2024 (Spain)
- Vaccine Financing - VACCINE CONGRESS 2024 (Spain)
- Vaccine Hesitancy - VACCINE CONGRESS 2024 (Spain)
- Vaccine Hesitancy: Causes and Solutions - Vaccines R&D 2024 (Netherlands)
- Vaccine Immunogenicity - VACCINE CONGRESS 2024 (Spain)
- Vaccine Manufacturing - VACCINE CONGRESS 2024 (Spain)
- Vaccine Policy and Regulation - VACCINE CONGRESS 2024 (Spain)
- Vaccine Safety - VACCINE CONGRESS 2024 (Spain)
- Vaccine Safety and Adverse Event Monitoring - VACCINES WORLD 2024 (Canada)
- Vaccine Surveillance - VACCINE CONGRESS 2024 (Spain)
- Vaccines Epidemiology - VACCINE CONGRESS 2024 (Spain)
- Vaccines for Non-Communicable Diseases - VACCINES WORLD 2024 (Canada)
- Vaccines Immunology - VACCINE CONGRESS 2024 (Spain)
- Viral Diagnostics - Virology 2024 (Austria)
- Viral Genomics and Evolution - Virology 2024 (Austria)
- Viral Immunology - Virology 2024 (Austria)
- Viral Pathogenesis - Virology 2024 (Austria)
- Viral Vaccines - Virology 2024 (Austria)